- Home
- LPSN vs BCTX Comparison
LPSN vs BCTX Comparison
Compare LPSN & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPSN | BCTX |
|---|---|---|
| Founded | 1995 | 2014 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.3M | 28.8M |
| IPO Year | 2000 | 2025 |
Fundamental Metrics
Financial Performance| Metric | LPSN | BCTX |
|---|---|---|
| Price | $2.31 | $3.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $40.00 |
| AVG Volume (30 Days) | 111.1K | ★ 235.6K |
| Earning Date | 05-06-2026 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $249,838,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $380.95 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.39 | $0.61 |
| 52 Week High | $7.54 | $14.68 |
Technical Indicators
Market Signals| Indicator | LPSN | BCTX |
|---|---|---|
| Relative Strength Index (RSI) | 46.22 | 44.90 |
| Support Level | $0.88 | $2.98 |
| Resistance Level | $2.78 | $4.51 |
| Average True Range (ATR) | 0.12 | 0.31 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 57.06 | 45.96 |
Price Performance
Historical ComparisonAbout LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Companies enterprise-class digital customer conversation platform, is trusted by the brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United States, Asia-Pacific, Latin America, and Europe.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.